The story of Viagra, formerly marketed by copyright, presents a intricate case study for backers considering the healthcare arena . Despite its initial success and impact of countless in sales, the exclusivity end has opened the floodgates for competing medications, greatly diminishing earnings prospects . This shift raises doubts about the continu